GlassScriptPhysician profile
Sara L Lemin
NPI 1053539866
$1,388.52
in general payments reported to CMS, 2019-2025
27 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $15.44 · 2021: $123 · 2022: $301 · 2023: $348 · 2024: $275 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.53 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $264.75 | 2022-2025 | Veozah |
| Abbvie INC. | $184.27 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $110.51 | 2022-2025 | Slynd |
| Channel Medsystems, INC. | $101.48 | 2023 | |
| Myovant Sciences INC. | $97.78 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $77.79 | 2023-2024 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $71.69 | 2023 | Ova1 |
| Ethicon US, LLC | $57.53 | 2022 | |
| Mylan Pharmaceuticals INC. | $56.72 | 2021-2022 | |
| Coopersurgical, INC. | $55.95 | 2022-2025 | Paragard T 380a |
| Becton, Dickinson and Company | $36.88 | 2024 | Arista Ah Flexitip |
| Convatec INC. | $27.26 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $25.63 | 2025 | |
| Novartis Pharmaceuticals Corporation | $22.71 | 2019 | |
| Sage Therapeutics, LLC | $20.38 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.45 | 2024 | |
| Novo Nordisk INC | $18.42 | 2021 | |
| Hologic Sales and Service, LLC | $15.58 | 2021 | |
| Virtus Pharmaceuticals LLC | $15.51 | 2021 | |
| Axonics, INC. | $15.40 | 2024 | Axonics |
| Organon LLC | $15.09 | 2025 | Jada System |
| Daiichi Sankyo INC. | $14.47 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.45 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.58 | 2019 | |
| Duchesnay USA Incorporated | $12.20 | 2019 | |
| Roche Diagnostics Corporation | $12.15 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Lemin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.